These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39278454)
1. Long non-coding RNA LNC-POTEM-4 promotes HCC progression via the LNC-POTEM-4/miR-149-5p/Wnt4 signaling axis. Lin C; Wu J; Wang Z; Xiang Y Cell Signal; 2024 Dec; 124():111412. PubMed ID: 39278454 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485 [TBL] [Abstract][Full Text] [Related]
3. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition. Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906 [TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA Gong X; Zhu Z Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535 [No Abstract] [Full Text] [Related]
5. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Li Y; Liu G; Li X; Dong H; Xiao W; Lu S Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
7. TGF-β1-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p/TGFBR2-SAMD2-SMAD3 Axis. Yang X; Xu C; Liu C; Wu X; Chen X; Hou J; Wang L Funct Integr Genomics; 2024 Jul; 24(4):123. PubMed ID: 38992207 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression. Zhu H; Zhang H; Pei Y; Liao Z; Liu F; Su C; Liu Y; Dong R; Song J; Zhang X; Fan Y; Liang H; Zhang B; Chen X J Exp Clin Cancer Res; 2021 Feb; 40(1):57. PubMed ID: 33541391 [TBL] [Abstract][Full Text] [Related]
9. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis. Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401 [TBL] [Abstract][Full Text] [Related]
10. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging. Li Y; Chen G; Yan Y; Fan Q Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158 [TBL] [Abstract][Full Text] [Related]
11. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
12. LncSNHG3 promotes hepatocellular carcinoma epithelial mesenchymal transition progression through the miR-152-3p/JAK1 pathway. Li H; Wu Y; Wang R; Guo J; Yu Q; Zhang L; Zhao H; Yang H Genes Genomics; 2022 Jan; 44(1):133-144. PubMed ID: 34778942 [TBL] [Abstract][Full Text] [Related]
13. CircGNAO1 suppresses hepatocellular carcinoma progression and metastasis via sponging miR-182-5p and regulating FOXO1 expression. Ju L; Luo Y; Shan J; Lu R; Chen L; Shao J; Bian Z; Yao M Int Immunopharmacol; 2024 Oct; 140():112873. PubMed ID: 39098231 [TBL] [Abstract][Full Text] [Related]
14. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway. Liu J; Liu R; Liu Y; Li L; Cao H; Liu J; Cao G Cell Cycle; 2021 Jun; 20(12):1134-1146. PubMed ID: 34097562 [TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma. Pan Y; Tong S; Cui R; Fan J; Liu C; Lin Y; Tang J; Xie H; Lin P; Zheng T; Yu X Cell Physiol Biochem; 2018; 50(1):108-120. PubMed ID: 30278452 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway. Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983 [TBL] [Abstract][Full Text] [Related]